Usana Health Sciences Inc (NYSE:USNA) currently has a daily average trading volume of 209.40K but it saw 261409 shares traded in last market. With a market cap of 447.74M USD, the company’s current market price of $23.74 came rising about 1.32 while comparing to the previous closing price of $23.43. In past 52 weeks, the stock remained buoying in the range of price level as high as $49.78 and as low as $23.28. In the recent trading on the day, stock has struck highest price mark of $23.385 while lowest mark touched by it was $24.22.
Taking a look at 20-day trading activity of Usana Health Sciences Inc (USNA) gives us an average price of $25.78, while its current price level is -52.31% below from 52-week high level whereas it is 1.98% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $28.81 while that of 200 days or SMA-200 reads an average of $36.01. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.68% during that period while stretching the period over a month that increases to 4.07%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 31.52 which implies that the stock is in neutral territory.
Jefferies downgraded its recommendation for the stock as a “Underperform” from “Hold” on July 07, 2022 while assigning a price target range of $78-$53. DA Davidson also issued its recommendations for the stock as it initiated the price target for the stock is $86.
Over the week, USNA’s stock price is moving -4.04% down while it is -13.80% when we observe its performance for the past one month. Year-to-date it is -33.85% down and over the past year, the stock is showing a downside performance of -45.03%.
The company is expected to be releasing its next quarterly report on 2025-Feb-24, for which analysts forecasted an EPS of 0.7 while estimate for next year EPS is 2.59. In next quarter, company is expected to be making quarterly sales of $220.37M as analysts are expecting the sales for current fiscal year at $941.62M and seeing the company making $1B in sales next year. Moreover, analysts are in estimates of $243.04M for current-quarter revenue.
Currently, Usana Health Sciences Inc’s total number of outstanding shares is 19.06M. Company’s return on investment (ROI) stands at 7.05% and return on equity (ROE) at 7.76%. It has a price to earnings ratio (P/E ratio) of 10.84 while having a 7.00 of forward P/E ratio. Stock’s beta reads 0.65. Stock has a price to book (P/B) ratio of 0.85 while price to sale or P/S ratio amounts to 0.52. Its return on asset (ROA) is 6.09% on average.
